COMPASS Pathways plc (NASDAQ:CMPS) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, COMPASS ...

COMPASS Pathways continues to make solid progress in its ambition to gain regulatory approval for COMP360 psilocybin-assisted therapy for treatment-resistant depression. The group has refined its ...

We have seen 64 institutional investors add shares of $CMPS stock to their portfolio, and 64 decrease their positions in their most recent quarter.

Investors might want to bet on COMPASS Pathways PLC Sponsored ADR (CMPS), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

We have seen 62 institutional investors add shares of $CMPS stock to their portfolio, and 45 decrease their positions in their most recent quarter.

Psilocybin is shown to be effective at treating a wide range of illnesses. COMP360 is in phase 3 clinical trials for treating treatment-resistant depression. No other psilocybin-oriented substance is ...